Amphotericin B resistance in Lomentospora prolificans is associated with a soluble cell wall component.

IF 4.2 2区 医学 Q2 MICROBIOLOGY
Antimicrobial Agents and Chemotherapy Pub Date : 2026-10-07 Epub Date: 2026-09-16 DOI:10.1128/aac.00915-26
Nina T Grossman, Arturo Casadevall
{"title":"Amphotericin B resistance in <i>Lomentospora prolificans</i> is associated with a soluble cell wall component.","authors":"Nina T Grossman, Arturo Casadevall","doi":"10.1128/aac.00915-26","DOIUrl":null,"url":null,"abstract":"<p><p><i>Lomentospora prolificans</i> is a pathogenic filamentous fungus that causes disease primarily in people with severely compromised immune systems. It is pan-resistant to antifungal drugs, but the mechanism of its resistance to amphotericin B (AMB) is unknown. In this study, our goal was to investigate the mechanism of resistance to AMB of <i>L. prolificans</i>. The AMB susceptibility of <i>L. prolificans</i> protoplasts were measured using broth microdilution. <i>L. prolificans</i>, either intact, homogenized, or fractionated, was incubated with AMB in broth. The same activity was carried out with <i>Aspergillus fumigatus</i> as a control. These broths were then used to prepare microdilution plates with <i>Saccharomyces cerevisiae</i> to determine the activity of the conditioned AMB. AMB was 16-fold more effective at inhibiting the growth of <i>L. prolificans</i> protoplasts than conidia, but only 2-fold more effective against <i>A. fumigatus</i> protoplasts than conidia. Incubation of <i>L. prolificans</i> hyphae with AMB in media diminished drug activity to a much greater extent than <i>A. fumigatus</i>, with an 8-fold greater fungal mass of the latter required to achieve the effect of the former. Homogenization and fractionation of <i>L. prolificans</i> revealed that the factor inhibiting AMB activity was soluble with a mass >100 kDa. DNase, trypsin, proteinase K, amyloglucosidase, SDS, and 0.22 μm filtration had no effect on the AMB resistance factor, while treatment with urea and acetonitrile inactivated it. In summary, we report a different mechanism for AMB resistance for <i>L. prolificans</i> based on the existence of a substance residing in the cell wall that can eliminate the antifungal activity of AMB.</p>","PeriodicalId":8152,"journal":{"name":"Antimicrobial Agents and Chemotherapy","volume":" ","pages":"e0091526"},"PeriodicalIF":4.2000,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13688863/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Agents and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/aac.00915-26","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Lomentospora prolificans is a pathogenic filamentous fungus that causes disease primarily in people with severely compromised immune systems. It is pan-resistant to antifungal drugs, but the mechanism of its resistance to amphotericin B (AMB) is unknown. In this study, our goal was to investigate the mechanism of resistance to AMB of L. prolificans. The AMB susceptibility of L. prolificans protoplasts were measured using broth microdilution. L. prolificans, either intact, homogenized, or fractionated, was incubated with AMB in broth. The same activity was carried out with Aspergillus fumigatus as a control. These broths were then used to prepare microdilution plates with Saccharomyces cerevisiae to determine the activity of the conditioned AMB. AMB was 16-fold more effective at inhibiting the growth of L. prolificans protoplasts than conidia, but only 2-fold more effective against A. fumigatus protoplasts than conidia. Incubation of L. prolificans hyphae with AMB in media diminished drug activity to a much greater extent than A. fumigatus, with an 8-fold greater fungal mass of the latter required to achieve the effect of the former. Homogenization and fractionation of L. prolificans revealed that the factor inhibiting AMB activity was soluble with a mass >100 kDa. DNase, trypsin, proteinase K, amyloglucosidase, SDS, and 0.22 μm filtration had no effect on the AMB resistance factor, while treatment with urea and acetonitrile inactivated it. In summary, we report a different mechanism for AMB resistance for L. prolificans based on the existence of a substance residing in the cell wall that can eliminate the antifungal activity of AMB.

增殖性绵孢菌对两性霉素B的抗性与一种可溶性细胞壁成分有关。
增殖性扁孢子菌是一种致病性丝状真菌,主要在免疫系统严重受损的人群中引起疾病。它对抗真菌药物具有泛耐药,但其对两性霉素B (AMB)的耐药机制尚不清楚。在本研究中,我们的目的是探讨增生性乳杆菌对AMB的抗性机制。采用肉汤微量稀释法测定了增生性乳杆菌原生质体对AMB的敏感性。将完整的、均质化的或分离的增殖乳杆菌与AMB在肉汤中孵育。以烟曲霉为对照,也进行了同样的活性测定。然后用这些培养液制备带有酿酒酵母的微稀释板,以测定条件AMB的活性。AMB对L. prolificans原生质体的抑制作用是分生孢子的16倍,而对烟曲霉原生质体的抑制作用仅是分生孢子的2倍。与AMB在培养基中孵育增殖乳杆菌菌丝时,其药物活性的降低程度要比烟曲霉大得多,后者需要比后者多8倍的真菌质量才能达到前者的效果。增殖乳杆菌均质分离表明,抑制AMB活性的因子可溶,质量约为100 kDa。脱氧核糖核酸酶、胰蛋白酶、蛋白酶K、淀粉葡糖苷酶、SDS和0.22 μm过滤对AMB抗性因子无影响,尿素和乙腈处理使其失活。综上所述,我们报道了一种不同的增殖性乳杆菌对AMB耐药的机制,基于细胞壁中存在一种物质,可以消除AMB的抗真菌活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.00
自引率
8.20%
发文量
762
审稿时长
3 months
期刊介绍: Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书